Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patientsXu Yang, Haitao Zhao, Junyu Long et al.|Hepatology International|2023Cited by 60
The evolution of T-cell receptor repertoire in different stages of non-small cell lung cancerZiqi Jia, Naixin Liang, Yadong Wang et al.|Research Square (Research Square)|2020Cited by 0